CA Patent

CA2018443A1 — Imidazolyl-alkenoic acids

Assigned to SmithKline Beecham Corp · Expires 1990-12-14 · 35y expired

What this patent protects

ABSTRACT OF THE DISCLOSURE IMIDAZOLYL-ALKENOIC ACIDS Angiotensin II receptor antagonists having the formula: which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, …

USPTO Abstract

ABSTRACT OF THE DISCLOSURE IMIDAZOLYL-ALKENOIC ACIDS Angiotensin II receptor antagonists having the formula: which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.

Drugs covered by this patent

Patent Metadata

Patent number
CA2018443A1
Jurisdiction
CA
Classification
—
Expires
1990-12-14
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.